Vericel Stock (NASDAQ: VCEL) stock price, news, charts, stock research, profile.
Open | $44.98 |
Close | $46.68 |
Volume / Avg. | 332.28K / 371.30K |
Day Range | 44.68 - 46.88 |
52 Wk Range | 30.18 - 53.05 |
Market Cap | $2.27B |
P/E Ratio | 4.49K |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 16.39% |
Days to Cover | 13.78 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vericel (NASDAQ:VCEL) through any online brokerage.
Other companies in Vericel’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), MoonLake (NASDAQ:MLTX), PTC Therapeutics (NASDAQ:PTCT), Protagonist Therapeutics (NASDAQ:PTGX) and Agios Pharmaceuticals (NASDAQ:AGIO).
There is no analysis for Vericel.
Vericel has a consensus price target of $45.70.
The stock price for Vericel (NASDAQ: VCEL) is $46.68 last updated Today at July 5, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Vericel.
Vericel’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
There is no upcoming split for Vericel.
Vericel is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.